Helen C. Adams
CIK 1488486 · last filed 2026-05-29
Helen C. Adams is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for IMMX, was dated May 29, 2026. Across all open-market trades the lifetime net is +$48.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.53M
3
14
$48.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMMX | Director | 181,004 | $8.45 | $1.53M | $38.5K | 7 | 2026-05-29 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | Director | 0 | $199.92 | $0 | $9.5K | 5 | 2023-06-16 |
| Genasys Inc. (LRAD) Delisted | Director | — | — | — | $0 | 2 | 2012-05-10 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-29 | IMMX | Grant (A) | +6,250 | $0 | EDGAR |
| 2025-06-23 | IMMX | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | IMMX | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | IMMX | Grant (A) | +161,981 | $0 | EDGAR |
| 2023-09-14 | IMMX | Buy (P) | +13,000 | $38.5K | EDGAR |
| 2023-08-14 | IMMX | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Prometheus Biosciences, Inc. (RXDX) Delisted | Disp (D) | −2,674 | $0 | EDGAR |
| 2023-05-19 | Prometheus Biosciences, Inc. (RXDX) Delisted | Grant (A) | +2,174 | $0 | EDGAR |
| 2022-07-18 | IMMX | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | Prometheus Biosciences, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |